Tevogen Bio Holdings Inc. announced a collaboration with Databricks, Inc. to enhance its AI-driven target prediction model, PredicTcell, aimed at precision immunotherapy development. Databricks will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results